Jeremy S. Connors, MD
Department of Pediatrics, Division of Pediatrics
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Pediatrics - Patient Care, Stem Cell Transplantation and Cellular Therapy Section, Department of Pediatrics Patient Care, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Program Director, Pediatric Hematology/Oncology Fellowship, Department of Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2015 | Rutgers Health - New Jersey Medical School, Newark, New Jersey, US, MD |
| 2010 | Stevens Institute of Technology, Hoboken, New Jersey, US, Biomedical Engineering, BE |
Postgraduate Training
| 2022-2023 | Chief Fellowship, Pediatrics - Hematology and Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2020-2022 | Clinical Fellowship, Pediatrics - Hematology and Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2019-2020 | Chief Residency, Pediatrics, Rutgers Health - New Jersey Medical School, Newark, New Jersey |
| 2019-2020 | Chief Residency, Pediatrics, Hackensack University Medical Center - Hackensack Meridian School of Medicine, Hackensack, New Jersey |
| 2018-2019 | Chief Residency, Internal Medicine and Pediatrics, Rutgers Health - New Jersey Medical School, Newark, New Jersey |
| 2016-2019 | Clinical Residency, Internal Medicine and Pediatrics Residency, Rutgers Health - New Jersey Medical School, Newark, New Jersey |
| 2015-2016 | Clinical Internship, Internal Medicine and Pediatrics, Rutgers Health - New Jersey Medical School, Newark, New Jersey |
Licenses & Certifications
| 2021 | Texas Medical Board |
| 2020 | The American Board of Pediatrics (ABP) |
| 2019 | The American Board of Internal Medicine (ABIM) |
Experience & Service
Extramural Institutional Committee Activities
Fellow Representative, Pharmaceutical and Therapeutics Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Pediatric Clinical Practice Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Pediatric Diversity, Equity, and Inclusion Committee, The University of Texas MD Anderson Cancer Center, 2022 - 2023
Member, Non-Punitive Response to Error and Psychological Safety Task Force, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Pediatric Hematology/Oncology Fellowship Program Evaluation Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present
Honors & Awards
| 2019 | Richard H. Rapkin, MD Senior Resident of the Year |
| 2017 | NJMS Golden Apple Award, Rutgers New Jersey Medical School |
| 2016 | Humanism and Excellence in Teaching Award, Arnold P. Gold Foundation |
| 2015 | Dean Charles L. Brown Award, Rutgers New Jersey Medical School |
Professional Memberships
Selected Presentations & Talks
Regional Presentations
- 2017. Keynote Address: Engagement on Transitioning Pediatric Hematology/Oncology Patients to Adult Care. Conference. Keynote Address: Engagement on Transitioning Pediatric Hematology/Oncology Patients to Adult Care. New Brunswick, NJ, US.
- 2014. Keynote Address: Role of Vaccinations in Prevention of HIV and other Infectious Diseases. Conference. Keynote Address: Role of Vaccinations in Prevention of HIV and other Infectious Diseases. New York, NY, US.
International Presentations
- 2022. Extensive Thrombosis from Cranial Venous Sinuses to Superior Vena Cava in an Infant with Lemierre Syndrome with Successful Management. Conference. Extensive Thrombosis from Cranial Venous Sinuses to Superior Vena Cava in an Infant with Lemierre Syndrome with Successful Management. London, GB.
Selected Publications
Peer-Reviewed Articles
- Raj R, Catueno S, Gibson A, McCall D, Garcia MB, Nunez C, Roth ME, Sasaki K, Tewari P, Issa GC, Farhat A, Connors JS, Sheikh IN, Nishida Y, Yi JS, Stevens AM, Bataller A, Bhalla KN, Petropoulos D, Daver NG, Kadia TM, Cuglievan B, DiNardo CD. FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AML. Blood 146(21):2608-2611, 2025. e-Pub 2025. PMID: 40971491.
- He J, Connors J, Meador A, Xu S, Meador H, Jiang H, Fueyo J, Gomez-Manzano C, Friedman GK, Zaky W, Sadighi Z, Slopis JM, Ahmad AH. Immunotherapy-Related Neurotoxicity in the Central Nervous System of Children with Cancer. Neuro Oncol 27(3):625-643, 2024. e-Pub 2024. PMID: 39535217.
- Gibson A, Dickson S, McCall D, Garcia M, Connors J, He J, Roth M, Nunez C, Cuglievan B. Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia. Pediatr Blood Cancer 71(11):e31286, 2024. e-Pub 2024. PMID: 39152634.
- Lucas BJ, Connors JS, Wang H, Conneely S, Cuglievan B, Garcia MB, Rau RE. Observation and Management of Juvenile Myelomonocytic Leukemia and Noonan Syndrome-Associated Myeloproliferative Disorder: A Real-World Experience. Cancers (Basel) 16(15), 2024. e-Pub 2024. PMID: 39123476.
- He J, Garcia MB, Connors JS, Nuñez CA, Quesada AE, Gibson A, Roth M, Cuglievan B, Pemmaraju N, McCall D. Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm. J Pediatr Hematol Oncol 45(8):E1001-E1004, 2023. e-Pub 2023. PMID: 37661300.
- Zertuche JP, Connors J, Scheinman A, Kothari N, Wong K. Using virtual reality as a replacement for hospital tours during residency interviews. Med Educ Online 25(1):1777066, 2020. e-Pub 2020. PMID: 32497472.
- Mathema B, Lewis JJ, Connors J, Chihota VN, Shashkina E, van der Meulen M, Graviss EA, Ha NP, Kreiswirth BN, Grant AD, Fielding KL, Dorman SE, Churchyard GJ. Molecular epidemiology of Mycobacterium tuberculosis among South African gold miners. Ann Am Thorac Soc 12(1):12-20, 2015. e-Pub 2015. PMID: 25419914.
Review Articles
- Cuglievan B, Kantarjian H, Rubnitz JE, Cooper TM, Zwaan CM, Pollard JA, DiNardo CD, Kadia TM, Guest E, Short NJ, McCall D, Daver N, Nunez C, Haddad FG, Garcia M, Bhalla KN, Maiti A, Catueno S, Fiskus W, Carter BZ, Gibson A, Roth M, Khazal S, Tewari P, Abbas HA, Bourgeois W, Andreeff M, Shukla NN, Truong DD, Connors J, Ludwig JA, Stutterheim J, Salzer E, Juul-Dam KL, Sasaki K, Mahadeo KM, Tasian SK, Borthakur G, Dickson S, Jain N, Jabbour E, Meshinchi S, Garcia-Manero G, Ravandi F, Stein EM, Kolb EA, Issa GC. Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community. Leukemia 38(10):2073-2084, 2024. e-Pub 2024. PMID: 39179671.
- He, J, Munir, F, Catueno, S, Connors, JS, Gibson, A, Robusto, L, McCall, DC, Nunez, CA, Roth, M, Tewari, P, Garces, S, Cuglievan, B, Garcia, MB. Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia. Cancers 16(5), 2024. e-Pub 2024. PMID: 38473221.
- Cuglievan B, Connors J, He J, Khazal S, Yedururi S, Dai J, Garces S, Quesada AE, Roth M, Garcia M, McCall D, Gibson A, Ragoonanan D, Petropoulos D, Tewari P, Nunez C, Mahadeo KM, Tasian SK, Lamble AJ, Pawlowska A, Hammond D, Maiti A, Haddad FG, Senapati J, Daver N, Gangat N, Konopleva M, Meshinchi S, Pemmaraju N. Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies. Leukemia 37(9):1767-1778, 2023. e-Pub 2023. PMID: 37452102.
- Munir F, He J, Connors J, Garcia M, Gibson A, McCall D, Nunez C, Dinh CN, Robusto L, Roth M, Khazal S, Tewari P, Cuglievan B. Translational advances in the treatment of childhood acute lymphoblastic leukemia: narrative review of current and emerging molecular and immunotherapies. Transl Pediatr 12(3):487-502, 2023. e-Pub 2023. PMID: 37035397.
Editorials
- Okeleji, O, McCall, DC, Gibson, A, Garcia, MB, Nunez, CA, Roth, M, Connors, JS, Petropoulos, D, Tewari, P, Cuglievan, B, Sheikh, IN. Post transplant maintenance therapy with newly FDA-approved revumenib for high-risk KMT2Ar acute leukemia. Blood Advances 9(8):1988-1990, 2025. PMID: 39993239.
Book Chapters
- Irastorza L, Janssen A, Kelly B, Connors JS. Child and Adolescent Medicine. In: The Equal Curriculum. 1. Springer, 91-105, 2020.
- Casares, MC, Honigberg, MC, Davis, JA, Connors JS. LGBTQ Health Disparities. In: The Equal Curriculum. 1. Springer, 13-31, 2020.
Letters to the Editor
- Sheikh, IN, Alqahtani, S, Okeleji, O, Brown, BD, Ragoonanan, D, Waseemuddin, M, Shoberu, B, Kawedia, J, Khazal, SJ, Connors, JS, Petropoulos, D, Tewari, P, Bonfim, C, Driscoll, TA, DePriest, BP, Mahadeo, KM. Pre-transplant immunosuppression in pediatric patients undergoing haploidentical stem cell transplant for sickle cell disease is associated with positive outcomes. Bone marrow transplantation 61: 241-244, 2026.
- Okeleji, O, Khazal, SJ, Mahadeo, KM, Ragoonanan, D, Rodriguez, NI, DiNardo, C, Connors, JS, Petropoulos, D, Tewari, P, Sheikh, IN. Allogeneic Hematopoietic Stem Cell Transplant for an Unknown Inherited Bone Marrow Failure Syndrome With a Novel Compound Heterozygous Mutation. Pediatric Blood and Cancer 72, 2025.
- Sarkar, S, Rav, ES, Stitzlein, LM, Gibson, A, McCall, DC, Nunez, CA, Roth, M, Ragoonanan, D, Connors, JS, Herzog, CE, Cuglievan, B, Garcia, MB. Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR-T cell therapy in KMT2A-rearranged, therapy-related acute lymphoblastic leukemia. Pediatric Blood and Cancer 71, 2024.
- Sheikh, IN, Alqahtani, S, Yin, CC, McCall, DC, Cuglievan, B, Ragoonanan, D, Connors, JS, Gibson, A, Nunez, CA, Roth, M, Ohanian, M, Borthakur, G, Garcia, MB. KIT-mutated pediatric core-binding factor systemic mastocytosis-acute myeloid leukemia treated with avapritinib and decitabine. Pediatric Blood and Cancer 71, 2024.
Patient Reviews
CV information above last modified March 06, 2026